ZA966617B - New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters). - Google Patents

New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).

Info

Publication number
ZA966617B
ZA966617B ZA9606617A ZA966617A ZA966617B ZA 966617 B ZA966617 B ZA 966617B ZA 9606617 A ZA9606617 A ZA 9606617A ZA 966617 A ZA966617 A ZA 966617A ZA 966617 B ZA966617 B ZA 966617B
Authority
ZA
South Africa
Prior art keywords
thioesters
acyl
pct
new methods
acid ester
Prior art date
Application number
ZA9606617A
Other languages
English (en)
Inventor
Brian Robert Krause
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA966617B publication Critical patent/ZA966617B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9606617A 1995-08-04 1996-08-02 New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters). ZA966617B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04

Publications (1)

Publication Number Publication Date
ZA966617B true ZA966617B (en) 1997-02-18

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606617A ZA966617B (en) 1995-08-04 1996-08-02 New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).

Country Status (27)

Country Link
US (1) US6117909A (hr)
EP (1) EP0841913B1 (hr)
JP (1) JPH11510184A (hr)
KR (1) KR19990036127A (hr)
CN (1) CN1192140A (hr)
AT (1) ATE232097T1 (hr)
AU (1) AU716255B2 (hr)
BG (1) BG63863B1 (hr)
CA (1) CA2221729A1 (hr)
CZ (1) CZ26198A3 (hr)
DE (1) DE69626118T2 (hr)
DK (1) DK0841913T3 (hr)
EA (1) EA002435B1 (hr)
EE (1) EE9800037A (hr)
ES (1) ES2191762T3 (hr)
GE (1) GEP20012511B (hr)
HR (1) HRP960341A2 (hr)
HU (1) HUP9900668A3 (hr)
IL (1) IL122247A0 (hr)
NO (1) NO980466L (hr)
NZ (1) NZ312571A (hr)
PL (1) PL185943B1 (hr)
PT (1) PT841913E (hr)
SK (1) SK12598A3 (hr)
UA (1) UA46030C2 (hr)
WO (1) WO1997005868A1 (hr)
ZA (1) ZA966617B (hr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (en) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Use of acetylcoenzime A inhibitors for treating Alzheimer's disease
OA11584A (en) * 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
JP2003513909A (ja) * 1999-11-05 2003-04-15 ワーナー−ランバート・カンパニー Ａｃａｔ阻害剤によるプラーク破裂の予防
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
TWI815829B (zh) 2017-11-14 2023-09-21 美商默沙東有限責任公司 作為吲哚胺2,3-二氧酶(ido)抑制劑之新穎經取代二芳基化合物
US11498904B2 (en) 2017-11-14 2022-11-15 Merck Sharp & Dohme Llc Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
KR100193743B1 (ko) * 1990-10-30 1999-06-15 로즈 암스트롱, 크리스틴 에이. 트러트웨인 옥시술포닐 카르바메이트
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents

Also Published As

Publication number Publication date
JPH11510184A (ja) 1999-09-07
KR19990036127A (ko) 1999-05-25
HUP9900668A3 (en) 2000-08-28
CZ26198A3 (cs) 1998-07-15
CA2221729A1 (en) 1997-02-20
BG63863B1 (bg) 2003-04-30
EP0841913A1 (en) 1998-05-20
IL122247A0 (en) 1998-04-05
EP0841913B1 (en) 2003-02-05
NO980466D0 (no) 1998-02-03
AU716255B2 (en) 2000-02-24
ATE232097T1 (de) 2003-02-15
US6117909A (en) 2000-09-12
GEP20012511B (en) 2001-08-27
HRP960341A2 (en) 1998-02-28
ES2191762T3 (es) 2003-09-16
PL324908A1 (en) 1998-06-22
PL185943B1 (pl) 2003-09-30
HUP9900668A2 (hu) 1999-06-28
BG102222A (en) 1998-09-30
PT841913E (pt) 2003-06-30
WO1997005868A1 (en) 1997-02-20
SK12598A3 (en) 1999-02-11
DK0841913T3 (da) 2003-05-05
EA002435B1 (ru) 2002-04-25
EE9800037A (et) 1998-08-17
DE69626118D1 (de) 2003-03-13
NO980466L (no) 1998-02-03
UA46030C2 (uk) 2002-05-15
EA199800176A1 (ru) 1998-10-29
DE69626118T2 (de) 2003-11-27
AU6454196A (en) 1997-03-05
NZ312571A (en) 2000-07-28
CN1192140A (zh) 1998-09-02

Similar Documents

Publication Publication Date Title
GR3030356T3 (en) N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
ZA966617B (en) New methods of using n-acyl sulfamic acid ester (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters).
PE46799A1 (es) Aminofosfonatos sustituidos con grupos fenolicos y piridina
EA199800109A1 (ru) Производные азетидинона для лечения атеросклероза
HUP0003484A2 (hu) Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként
DK0775158T3 (da) Cyclopeptolider
DE69005974D1 (de) Heteroaryl-3-oxo-propannitril-derivate, nützlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
DE69616357T2 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
DE59407547D1 (de) Verfahren zur Herstellung von 2-substituierten 5-Chlorimidazol-4-carbaldehyden